JOVANA
Library Glossary Getting Started Three Levels Fields How it works Mission
Join the mission
All guides

The Inhaled Drugs: Openers, Calmers, and Combinations

Bronchodilators relax airway muscle; inhaled steroids calm inflammation. Learn the main families, what each is for, and why relievers and controllers play different roles.

Openers: bronchodilators

Around each airway is a ring of smooth muscle. When it tightens — bronchospasm — the tube narrows and breathing gets harder. Bronchodilators relax that muscle, opening the airway. There are two main switches. Beta-agonists act on β2 receptors to relax muscle quickly: a short-acting beta-agonist (SABA, the classic blue reliever) works within minutes for a few hours, while a long-acting beta-agonist (LABA) lasts 12–24 hours for daily control. Separately, antimuscarinics block the nerve signal that constricts airways and clears mucus.

Calmers: inhaled corticosteroids

In asthma, the core problem is inflammation in the airway lining. An inhaled corticosteroid (ICS) is the main controller: taken every day, it gradually quietens the inflammation, reduces eosinophilic inflammation, and prevents attacks. It is preventive, not a rescue — it will not relieve sudden breathlessness on the spot, and skipping it on good days lets inflammation creep back. Because it is inhaled at low doses, whole-body steroid side effects are uncommon; the main local effects are hoarseness and oral thrush, reduced by using a spacer and rinsing the mouth.

The roles differ by disease. In asthma, ICS is the foundation and bronchodilators support it. In COPD, long-acting bronchodilators are the foundation, and ICS is added mainly for people with frequent flare-ups or eosinophilic inflammation — used carefully, because in COPD steroids can slightly raise pneumonia risk.

Combinations and the bigger picture

Many people end up on more than one drug. A combination inhaler packs two or three of these into a single device — for example ICS plus LABA, or LABA plus antimuscarinic, or all three together. This improves convenience and adherence, since one device replaces two or three. Modern asthma care often uses a single ICS-LABA inhaler for both daily control and relief, so the controller and reliever are never separated.

A simple way to sort inhaled drugs:

RELIEVERS (act fast, short-lived) ---------------------
  SABA  e.g. salbutamol/albuterol   onset minutes, ~4-6 h
  (sometimes SAMA, a short-acting antimuscarinic)
  -> for sudden symptoms / before exercise

CONTROLLERS (taken daily, prevent symptoms) ----------
  ICS   inhaled corticosteroid       calms inflammation
  LABA  long-acting beta-agonist     12-24 h dilation
  LAMA  long-acting antimuscarinic   12-24 h dilation
  -> taken every day, even when feeling well

COMBINATIONS (controllers in one device) -------------
  ICS + LABA              common in asthma
  LABA + LAMA            common in COPD
  ICS + LABA + LAMA       "triple therapy"

Rule of thumb:
  asthma  -> ICS is the foundation
  COPD    -> long-acting bronchodilator(s) are the foundation
A cheat-sheet: relievers vs controllers vs combinations.